Results 221 to 230 of about 115,959 (294)

Targeting fibrosis in the treatment of lower urinary tract dysfunction

The Journal of Pathology, Volume 269, Issue 4-5, Page 493-503, August 2026.
Abstract Benign prostatic hyperplasia (BPH) is a widely prevalent age‐associated disease that is the main contributor to lower urinary tract dysfunction (LUTD) in aging men. Although prostate fibrosis has been recognized as a contributor to BPH pathophysiology, there are not any clinically available therapeutics that target this aspect of disease ...
Ajinkya R Limkar, Sophia M Vrba, Emily A Ricke, Zsuzsanna Fabry, Matthew S Lee, Kevin T McVary, William A Ricke   +6 more
wiley   +1 more source

First-in-human radiation dosimetry of the GRPR antagonist [⁶⁸Ga]Ga-NOTA-PEG₂-RM26 in patients with prostate and breast cancer. [PDF]

EJNMMI Res
Bjäreback A, Estenberg U, Tzortzakakis A, Axelsson R, Li C, Altena R, Tran TA, Hindorf C.   +7 more
europepmc   +1 more source

Advances in Smart Wearable Biosensors for Non‐Invasive and Microneedle‐Based Health Monitoring: A Physiological Fluids‐Based Approach

Small Structures, Volume 7, Issue 8, August 2026.
This review highlights recent advancements in smart wearable biosensors for non‐invasive, microneedle‐based health monitoring via physiological fluids. It focuses on functional materials, biomarker detection strategies, sensor integration and validation methods.
Shuva Bhowmik, Azam Ali
wiley   +1 more source

Leverage of quick-soluble gelatin microparticles in transarterial chemoembolization of canine urothelial carcinomas. [PDF]

Vet Q
Jeon S, Lee G, Kim JK, Lee N, Chang D.
europepmc   +1 more source

Ejaculatory Dysfunction and Minimally Invasive Surgical Treatments (MIST) for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement

Trends in Urology &Men's Health, Volume 17, Issue 4, August 2026.
ABSTRACT While transurethral resection of the prostate (TURP) is considered the standard surgical treatment in symptomatic benign prostatic enlargement (BPE) secondary to benign prostatic hyperplasia (BPH), it is not without surgical morbidities and has adverse impact on various sexual function domains such as ejaculatory dysfunction (EjD) and erectile
Haijun Yao, Tao Wang, Shan‐Chao Zhao, Lei Zheng, Rui Jiang, Han Wu, Jingjing Gao, Baibing Yang, Yuzhuo Yang, Haocheng Lin, Eric Chung   +10 more
wiley   +1 more source

Diagnostic Value of Spectral CT-Derived Extracellular Volume Fraction in the Early Detection of Sigmoid Colon Metastasis from Bladder Cancer: A Case Report. [PDF]

Surg Case Rep
Peng M, Shen L, Song D, Wen L, Xiang Y, Song L.   +5 more
europepmc   +1 more source

Prognostic Factors for Postoperative Complications. An Aggregate Protocol for 10 Observational Studies From the Danish TRIPLE‐A Cohort of 1.2 Million Surgeries

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 7, August 2026.
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen, Asta Prescott, Caroline Folkersen, Jens Laigaard, Atena Saito, Caroline Lando Klammer, Mik Wetterslev, Emil Ipsen Ørskov, Mathilde Fahrendorff, Rebecca Kiær, Helene Holm Laigaard, Nichlas Hovmand, Lars Hyldborg Lundstrøm, Sebastian Buhl Rasmussen, Anders Kehlet Nørskov, Markus Harboe Olsen   +15 more
wiley   +1 more source

Contrast-enhanced ultrasound in the diagnosis of neoplastic lesions of the urinary bladder. [PDF]

Cent European J Urol
Kufel J, Mitręga A, Magiera M, Bielówka M.   +3 more
europepmc   +1 more source

Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta‐analysis

BJU International, Volume 138, Issue 2, Page 186-195, August 2026.
Objective To evaluate the concordance between clinical complete response (cCR) and pathological complete response (pCR) in muscle‐invasive bladder cancer (MIBC) to assess the surrogacy and prognostic value of cCR for guiding bladder‐sparing strategies.
Navid Roessler, Marcin Miszczyk, Paolo Gontero, Alessandro Dematteis, Keiichiro Miyajima, Shota Inoue, Katharina Oberneder, Markus von Deimling, Victor M. Schuettfort, Malte W. Vetterlein, Bernadett Szabados, Pawel Rajwa, Pierre I. Karakiewicz, Jeremy Yuen‐Chun Teoh, Margit Fisch, Shahrokh F. Shariat   +15 more
wiley   +1 more source

Total ureteral replacement with a small intestinal graft as a reconstructive stage of combined treatment for recurrent colorectal cancer: case report. [PDF]

Front Oncol
Efetov SK, Volgin MV, Koziy AY, Fokin IV, Azilgareeva CR, Paramonova NB, Enikeev ME, Kazaryan AM.   +7 more
europepmc   +1 more source